Mesenteric ischaemia encompasses a spectrum of acute and chronic vascular disorders characterised by an imbalance between intestinal blood supply and metabolic demand, frequently culminating in bowel infarction, multi-organ failure, and high mortality rates exceeding 50%1,3. Because the gastrointestinal tract possesses an extensive collateral network, clinical manifestations often remain subtle or non-specific until irreversible tissue necrosis occurs, making rapid clinical recognition and advanced cross-sectional imaging paramount for survival1,2.
1. Etiology & Risk Factors
- Superior Mesenteric Artery Embolism (SMAE): Accounts for approximately 50% of acute occlusive cases. Emboli typically originate from cardiac sources, such as atrial fibrillation, recent myocardial infarction, left ventricular mural thrombi, or valvular vegetations, and lodge most frequently in the main superior mesenteric artery 3 to 6 cm distal to its aortic origin due to vessel tapering and branching angles3,4.
- Superior Mesenteric Artery Thrombosis (SMAT): Accounts for 15% to 25% of cases and develops on pre-existing severe atherosclerotic stenosis at the origin of the superior mesenteric artery. Acute plaque rupture, low-flow states, or hypercoagulability precipitates complete vessel occlusion3,5.
- Mesenteric Venous Thrombosis (MVT): Represents 5% to 15% of acute cases, involving thrombosis of the superior mesenteric vein. Associated risk factors include inherited or acquired hypercoagulable states (e.g., Factor V Leiden mutation, protein C/S deficiency, antithrombin III deficiency, antiphospholipid syndrome, myeloproliferative neoplasms), intra-abdominal sepsis, recent abdominal surgery, portal hypertension, and local trauma3,6.
- Non-Occlusive Mesenteric Ischaemia (NOMI): Constitutes 20% to 30% of cases and occurs in the absence of mechanical vascular obstruction. It is driven by severe splanchnic vasoconstriction secondary to low-cardiac-output states, congestive heart failure, hypovolaemic shock, sepsis, cardiopulmonary bypass, or exogenous vasoconstrictive agents (e.g., high-dose vasopressors like norepinephrine, cocaine, or digitalis toxicity)1,5.
- Chronic Mesenteric Ischaemia (CMI): Typically results from progressive, multi-vessel atherosclerotic narrowing of at least two of the three main visceral vessels (celiac axis, superior mesenteric artery, and inferior mesenteric artery), leading to post-prandial visceral hypoperfusion ("intestinal angina") and potential progression to acute thrombotic occlusion2.
2. Pathophysiology
The pathophysiological cascade of mesenteric ischaemia begins with a critical reduction in microvascular perfusion to the intestinal mucosa and submucosa, which possess high metabolic rates and oxygen demands. As arterial inflow or venous outflow is compromised, cellular oxygen tension drops precipitously, forcing enterocytes to transition from aerobic oxidative phosphorylation to anaerobic glycolysis. This metabolic shift rapidly depletes intracellular adenosine triphosphate (adenosine triphosphate, ATP), disabling ATP-dependent sodium-potassium pumps ($\text{Na}^+/\text{K}^+$-ATPase). The resulting intracellular accumulation of sodium and water causes cellular swelling, cytoplasmic vacuolisation, and disruption of tight junctions between enterocytes1,5.
The mucosal barrier—the body's primary defense against luminal bacterial translocation—breaks down within hours of sustained ischaemia. Shedding of the villous tips occurs early, followed by hemorrhagic necrosis extending transmurally through the muscularis propria and serosa if perfusion is not restored. Concurrently, reperfusion injury compounds initial hypoxic damage: the re-establishment of blood flow introduces molecular oxygen that reacts with hypoxanthine accumulated during ischaemia via xanthine oxidase, generating massive bursts of cytotoxic reactive oxygen species (ROS), including superoxide radicals and hydroxyl radicals. These free radicals trigger lipid peroxidation, leukocyte infiltration, systemic release of pro-inflammatory cytokines (such as tumor necrosis factor-alpha and interleukins), and endothelial activation. The resultant systemic inflammatory response syndrome (SIRS) frequently precipitates capillary leak, systemic hypotension, myocardial depression, and multi-organ dysfunction syndrome (MODS)3,5,7.
3. Clinical Presentation & Classic Clinical Signs
- History & Cardinal Symptoms: The hallmark presentation of acute mesenteric ischaemia is severe, unrelenting, diffuse abdominal pain that is strikingly out of proportion to physical examination findings3. Patients with acute arterial embolism typically experience sudden, excruciating periumbilical pain accompanied by forceful bowel evacuation, vomiting, and profound apprehension. Patients with non-occlusive mesenteric ischaemia present with more insidious, generalized, and fluctuating abdominal discomfort superimposed on critical medical or surgical illness. In chronic mesenteric ischaemia, patients characteristically report severe post-prandial abdominal pain ("intestinal angina") beginning 15 to 30 minutes after eating, lasting 1 to 3 hours, leading to profound food fear (sitophobia) and marked, unintentional weight loss2,3.
- Physical Examination & Named Clinical Signs: In the early stages of acute ischaemia, the abdominal examination is remarkably benign, revealing a soft, non-tender, non-distended abdomen despite the patient's agonizing pain. As transmural necrosis and peritonitis supervene, physical signs evolve rapidly to demonstrate marked abdominal tenderness, guarding, muscular rigidity, absent bowel sounds, and rebound tenderness. Haemodynamic instability, tachycardia disproportionate to fever, metabolic acidosis, and signs of septic or hypovolaemic shock manifest in advanced, complicated disease1,3.
4. Diagnostic Workup & Interpretation (Laboratory, Imaging & ECG/Pathology)
| Diagnostic Modality / Test | Expected Clinical & Radiological / Laboratory Finding |
|---|---|
| Gold-Standard Investigation | Biphasic Computed Tomography Angiography (CTA): Performed with arterial and portal-venous phases. Demonstrates abrupt vascular cut-off or filling defects in the superior mesenteric artery or vein, lack of bowel wall enhancement, bowel wall thickening, mesenteric edema, pneumatosis intestinalis (gas within the bowel wall), and portomesenteric venous gas1,6. |
| Laboratory Panel | Leukocytosis (often $>15,000/\mu\text{L}$ with a left shift), elevated serum lactate (indicating cellular anaerobic metabolism and tissue necrosis, though a normal lactate does not exclude early ischaemia), elevated D-dimer (high sensitivity but low specificity), metabolic acidosis with elevated base deficit and anion gap, and rising serum creatinine secondary to dehydration or acute kidney injury1,5. |
| Imaging / Radiology (X-ray, US, CT, MRI) | Plain abdominal radiography is frequently normal or non-specific early on; late signs include "thumbprinting" (mucosal edema), dilated gas-filled bowel loops, and pneumoperitoneum indicating free perforation. Duplex ultrasound of mesenteric vessels is useful in chronic mesenteric ischaemia for assessing peak systolic velocities in the celiac axis and superior mesenteric artery (e.g., SMA peak systolic velocity $>275\text{ cm/s}$ indicates $>70\%$ stenosis), but is limited by bowel gas and operator dependence. Magnetic resonance angiography (MRA) provides high-resolution vascular mapping but is time-consuming and less suited for unstable emergency settings1,2. |
| ECG / Histopathology / Procedural | 12-lead ECG is mandatory to screen for atrial fibrillation or acute myocardial infarction as embolic sources. Diagnostic laparoscopy or exploratory laparotomy serves as the ultimate diagnostic and therapeutic procedure when peritoneal signs are unequivocally present. Histopathology of resected bowel confirms transmural coagulative necrosis, mucosal sloughing, and extensive neutrophilic infiltration3,5. |
5. Staging, Classification & Clinical Scoring Systems
| Criterion / Stage / Score Component | Clinical Threshold, Points & Management Implication |
|---|---|
| Etiologic Classification | Divided into four primary pathogenetic mechanisms: (1) Acute Occlusive Arterial Embolism, (2) Acute Occlusive Arterial Thrombosis, (3) Mesenteric Venous Thrombosis (MVT), and (4) Non-Occlusive Mesenteric Ischaemia (NOMI). Management pathways differ significantly between occlusive and non-occlusive subsets3,5. |
| Bowel Viability Staging (Intraoperative Grading) | Assessed by macroscopic inspection upon laparotomy: Viable bowel exhibits normal pink color, active peristalsis, and palpable mesenteric pulses; Questionable bowel shows dusky or mottled appearance with sluggish or absent peristalsis (managed with warm saline packs and reassessment or "second-look" laparotomy); Non-viable / Necrotic bowel displays black or green discoloration, complete loss of sheen, absent vascular pulsations, and flaccid, friable walls requiring immediate resection1,5. |
| ASGE / WSES Clinical Severity Grading | Stratified by the presence or absence of peritonitis and systemic instability. Stage I: No peritonitis, stable — candidate for endovascular revascularisation. Stage II: Mild/localised peritonitis or indeterminate abdomen — hybrid approach or exploratory surgery. Stage III: Diffuse peritonitis, septic shock, or intestinal perforation — emergency open laparotomy, revascularisation, and bowel resection1,5. |
6. Differential Diagnosis
| Differential Condition | Distinguishing Clinical, Biochemical & Imaging Features |
|---|---|
| Acute Pancreatitis | Epigastric pain radiating to the back, marked elevations in serum lipase and amylase ($>3\times$ upper limit of normal), and characteristic inflammatory fat stranding surrounding the pancreas on cross-sectional CT imaging. |
| Perforated Peptic Ulcer | Sudden onset of severe generalized abdominal pain with rigid board-like abdomen and pneumoperitoneum (free air under the diaphragm) visualised on erect chest or abdominal radiographs and CT scans. |
| Acute Small Bowel Obstruction (SBO) | Colicky abdominal pain, nausea, vomiting, obstipation, and high-pitched tinkling bowel sounds; CT demonstrates a clear transition point with proximal bowel dilation and distal decompression without primary vascular thrombosis. |
| Acute Diverticulitis / Appendicitis | Localized lower abdominal pain (left lower quadrant for diverticulitis, right lower quadrant for appendicitis), low-grade fever, focal peritoneal signs, and inflammatory fat stranding surrounding the affected colon or appendix on CT. |
7. Management & Treatment Protocol
- Initial Stabilization & Resuscitation: Institute immediate aggressive fluid resuscitation with weight-based crystalloids (e.g., lactated Ringer's solution) to restore effective circulating volume and visceral perfusion. Insert a nasogastric tube for gastric decompression in patients with vomiting or ileus, place an indwelling urinary catheter to monitor strict hourly urine output ($>0.5\text{ mL/kg/h}$), and correct severe electrolyte disturbances and metabolic acidosis1,2,5.
- First-Line Medical / Pharmacological Therapy: Administer broad-spectrum intravenous empiric antibiotics covering enteric gram-negative bacilli and anaerobes (e.g., piperacillin-tazobactam 4.5 g IV every 6 hours or meropenem 1 g IV every 8 hours). For confirmed acute arterial or venous thrombosis without immediate surgical emergency, initiate systemic anticoagulation with intravenous unfractionated heparin (initial weight-based bolus of 80 units/kg followed by a continuous infusion titrated to maintain an activated partial thromboplastin time [aPTT] of 1.5 to 2.5 times control). In non-occlusive mesenteric ischaemia (NOMI), selective intra-arterial infusion of vasodilators such as papaverine (administered at 30 to 60 mg/h via a superior mesenteric artery catheter) can reverse severe vasospasm1,5.
- Surgical / Interventional Indications:
- Endovascular Approach: Indicated in patients without clinical signs of peritonitis, bowel infarction, or free perforation. Procedures include percutaneous transluminal angioplasty (PTA) and stenting of the superior mesenteric artery, catheter-directed thrombolysis for acute venous or arterial thrombosis, or mechanical thrombectomy1,5.
- Open Surgical Approach: Mandatory for patients presenting with peritoneal signs, hemodynamic instability, or suspected bowel gangrene/perforation. Open interventions comprise surgical embolectomy via superior mesenteric arteriotomy, aortomesenteric bypass grafting using saphenous vein or prosthetic conduits, and exploratory laparotomy with resection of all non-viable or necrotic bowel segments. A mandatory planned "second-look" laparotomy is routinely performed 24 to 48 hours later to reassess borderline intestinal viability and avoid missing ongoing necrosis1,3,5.
8. Complications & Prognosis
- Acute Complications: Transmural bowel necrosis leading to acute peritonitis, intra-abdominal abscess formation, bowel perforation, sepsis, septic shock, multi-organ dysfunction syndrome (MODS), massive gastrointestinal haemorrhage, and reperfusion injury syndrome1,3,5.
- Chronic Complications: Short bowel syndrome resulting from extensive intestinal resection, requiring long-term parenteral nutrition and management of high-output ostomies; chronic malabsorption, protein-losing enteropathy, recurrent bowel strictures, and chronic abdominal pain or ischemic colitis sequelae1,5.
- Prognosis: The overall mortality rate for acute mesenteric ischaemia remains critically high at 50% to 90%, driven primarily by diagnostic delay and advanced transmural necrosis. Prognosis is exceptionally dependent on early diagnosis and timely revascularisation (ideally within 6 hours of symptom onset), which dramatically improves survival and bowel salvage rates1,3,4.
